AxoGen Profile

USD 0.1  0.5%
18.5Last Month High 20.0 
19.93Trading Day  High 20.4 

Acquisition by Karen Zaderej of 209500 shares of AxoGen subject to Rule 16b-3

AxoGen Inc insider trading alert for grant of employee stock option (right to purchase) by Karen Zaderej, CEO, on September 28, 2017. This event was filed by Axogen Inc with SEC on 2017-01-03. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

AxoGen Summary

AxoGen Inc (AXGN) is traded on Nasdaq Capital Markets in USA. It is located in FLORIDA, U.S.A and employs 113 people. AxoGen is listed under Medical Equipment category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 667.88 M. AxoGen Inc has 33.39 M outstanding shares of which 1.25 M shares are presently shorted by private and institutional investors with about 5.8 trading days to cover. AXOGEN INC currently holds about 23.87 M in cash with (9.83 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.72.
Check AxoGen Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Pennsylvania Trust CoCommon Shares142.4 K2.8 M
Bank Of MontrealCommon Shares12.6 K245 K
Cutler Group LpCall Options1.2 K11 K
Cutler Group LpPut Options6000.0
View AxoGen Diagnostics

Selected AxoGen Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

AxoGen Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
< 1% 
AxoGen, Inc. operates as a medical technology company. more
Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
NameAxoGen Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
RegionNorth America
LocationFLORIDA, U.S.A
Business AddressAxoGen, Inc.Alachua, FL
ExchangeNasdaq Capital Markets
CIK Number00805928.0
IndustryMedical Equipment
Contact Number386 462 6800
CurrencyUSD - US Dollar


AxoGen Analyst Recommendations
Target PriceAdvice# of Analysts
AxoGen Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
AxoGen Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


AxoGen Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.1February 22, 2017
AxoGen Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate